Does USTEKINUMAB Cause Death neonatal? 113 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Death neonatal have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.1% of all adverse event reports for USTEKINUMAB.
113
Reports of Death neonatal with USTEKINUMAB
0.1%
of all USTEKINUMAB reports
112
Deaths
11
Hospitalizations
How Dangerous Is Death neonatal From USTEKINUMAB?
Of the 113 reports, 112 (99.1%) resulted in death, 11 (9.7%) required hospitalization, and 27 (23.9%) were considered life-threatening.
Is Death neonatal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Death neonatal?
ACETAMINOPHEN (124)
ABATACEPT (123)
FOLIC ACID (122)
HYDROXYCHLOROQUINE (121)
ADALIMUMAB (120)
DICLOFENAC (120)
LEFLUNOMIDE (119)
INFLIXIMAB (118)
RITUXIMAB (118)
DESOXIMETASONE (117)
Which USTEKINUMAB Alternatives Have Lower Death neonatal Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE